Lantern Pharma Inc (NAS:LTRN)
$ 2.98 -0.010 (-0.34%) Market Cap: 38.02 Mil Enterprise Value: 31.25 Mil PE Ratio: 0 PB Ratio: 9.48 GF Score: 33/100

Q2 2023 Lantern Pharma Inc Earnings Call Transcript

Aug 09, 2023 / 08:30PM GMT
Release Date Price: $4.67 (+2.41%)
Nicole Leber
Lantern Pharma Inc. - IR

Good afternoon, everyone. I'm Nicole Leber with Investor Relations here at Lantern Pharma, and welcome to our second-quarter 2023 earnings call. I will be your host for today's call. As a reminder, this call is being recorded. (Event Instructions)

A webcast replay of today's conference call will be available on our website at lanternpharma.com shortly after the call. We issued a press release after market close today, summarizing our financial results and progress across the company for the second quarter ended June 30, 2023. A copy of this release is available through our website at lanternpharma.com where you will also find a link to the slides that management will be referencing on today's call.

I would like to remind everyone that remarks about future expectations, performance, estimates, and prospects constitute forward-looking statements for purposes of Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Lantern Pharma cautions that these forward-looking statements are subject to risks and uncertainties that may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot